Jones Financial Companies Lllp boosted its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 37.2% in the 4th quarter, ...
The UK’s National Institute for Health and Care Excellence (NICE) has issued further draft guidance reaffirming its decision ...
NICE is seeking public comment on the updated draft guidances through March 27, with plans to issue final draft guidances in July.
Spread the love Table of Contents Introduction Methodology Top 10 Biotech Giants Rising Stars (11-25) Innovators and ...
Biogen's BIIB short percent of float has risen 3.1% since its last report. The company recently reported that it has 3.88 ...
2d
Zacks Investment Research on MSNSLDB Stock Rallies 60% in a Month: Here's What You Should KnowShares of Solid Biosciences SLDB have rallied 59.9% in the past month. The stock price increase was mainly due to positive ...
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
Days after suffering a rejection in Australia, the Alzheimer’s drug hit another roadblock in the U.K., which found the drug ...
The results of the Intuition Brain Health study – sponsored by Biogen and supported by Apple – show the feasibility of using ...
England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...
A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...
The company confirmed this morning that NICE has taken the "unusual decision" to hold a third appraisal committee meeting as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results